Cheek Lesion Initially Diagnosed as MPNST Found to Be Desmoplastic Melanoma

A 71-year-old man underwent surgery for a cheek lesion initially misidentified as a rare sarcoma, highlighting the diagnostic risks in identifying desmoplastic melanoma.

The case, detailed in Cureus, demonstrates why clinicians must look beyond standard immunohistochemical markers when evaluating S100-positive spindle-cell tumors.

The patient, who manages a prosthetic heart valve with vitamin K antagonists, presented with a four-month history of an enlarging, ulcerated lesion on his left cheek. Initial biopsy results indicated the mass was a malignant peripheral nerve sheath tumor (MPNST), as it stained positive for S100 but lacked other common melanocytic markers like HMB45 and Melan-A.

Following this interpretation, the patient underwent an exofacial parotidectomy and wide excision of the mass. Surgeons preserved the facial nerve during the procedure, and postoperative recovery was uneventful. However, histopathology of the surgical specimen later confirmed the lesion was actually desmoplastic melanoma, not an MPNST.

Desmoplastic melanoma is a rare variant, accounting for approximately 1% to 4% of cutaneous melanomas, according to Cureus. It typically presents as a firm, amelanotic nodule in patients between 60 and 80 years old. Because the tumor often lacks traditional markers, it is frequently mistaken for other spindle-cell malignancies.

The diagnostic confusion in this case stemmed from the tumor’s specific immunophenotype and the limitations of a restricted biopsy panel. While S100 protein is highly sensitive for desmoplastic melanoma, it is not specific to the disease, leading to potential misdiagnosis when more definitive markers are absent.

The patient’s follow-up examinations at one and two months post-surgery showed no signs of recurrence. He remains under dermatologic observation as part of his ongoing care.

Photo of author

Health Desk

Health Desk at Archyde.

Universal UK Resort Targets 2031 Opening With £5 Billion Investment